Authors:
Bartholomew, A
Patil, S
Mackay, A
Nelson, M
Buyaner, D
Hardy, W
Mosca, J
Sturgeon, C
Siatskas, M
Mahmud, N
Ferrer, K
Deans, R
Moseley, A
Hoffman, R
Devine, SM
Citation: A. Bartholomew et al., Baboon mesenchymal stem cells can be genetically modified to secrete humanerythropoietin in vivo, HUM GENE TH, 12(12), 2001, pp. 1527-1541
Authors:
Devine, SM
Bartholomew, AM
Mahmud, N
Nelson, M
Patil, S
Hardy, W
Sturgeon, C
Hewett, T
Chung, T
Stock, W
Sher, D
Weissman, S
Ferrer, K
Mosca, J
Deans, R
Moseley, A
Hoffman, R
Citation: Sm. Devine et al., Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion, EXP HEMATOL, 29(2), 2001, pp. 244-255
Authors:
Devine, SM
Sanborn, R
Jessop, E
Stock, W
Huml, M
Peace, D
Wickrema, A
Yassine, M
Amin, K
Thomason, D
Chen, YH
Devine, H
Maningo, M
van Besien, K
Citation: Sm. Devine et al., Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem celltransplant, BONE MAR TR, 28(6), 2001, pp. 557-562
Authors:
Przepiorka, D
Devine, SM
Fay, JW
Uberti, JP
Wingard, JR
Citation: D. Przepiorka et al., Practical considerations in the use of tacrolimus for allogeneic marrow transplantation, BONE MAR TR, 24(10), 1999, pp. 1053-1056